Steve Colletti
Net worth: - $ as of 2024-04-29
Profile
Steve Colletti is currently the Chief Scientific Officer at Korro Bio, Inc. (United States) and Korro Bio, Inc. He previously worked as the SVP-Drug Discovery Research & Development at Zymergen, Inc. and as the Chief Scientific Officer at Lodo Therapeutics Corp.
Dr. Colletti holds a doctorate degree from Boston University and an undergraduate degree from Loyola University of Chicago.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
-.--% | 2024-04-16 | 0 ( -.--% ) | - $ | 2024-04-29 |
Steve Colletti active positions
| Companies | Position | Start |
|---|---|---|
Korro Bio, Inc.
 Korro Bio, Inc. BiotechnologyHealth Technology Korro Bio, Inc. engages in the development of a bio therapeutics. It focuses on a proprietary platform designed to selectively edit messenger RNA and recode specific codons to effect changes in protein structure and function across multiple tissues. The company was founded by Jean-Fran?ois Formela, Josh Rosenthal, Nessan Bermingham, and Andrew Fraley in 2018 and is headquartered in Cambridge, MA. | Chief Tech/Sci/R&D Officer | 2023-01-31 |
Former positions of Steve Colletti
| Companies | Position | End |
|---|---|---|
| ZYMERGEN INC. | Corporate Officer/Principal | 2022-12-31 |
Lodo Therapeutics Corp.
 Lodo Therapeutics Corp. BiotechnologyHealth Technology Lodo Therapeutics Corp. engages in the development of novel therapeutics from its metagenomics-based small molecule discovery platform. Its Lodo platform leverages breakthroughs in next-generation sequencing (NGS), artificial intelligence (AI), and machine learning (ML), along with advances in synthetic biology and automation. The company was founded by Sean Brady and David L. Pompliano and is headquartered in New York, NY. | Chief Tech/Sci/R&D Officer | 2021-04-30 |
Training of Steve Colletti
| Boston University | Doctorate Degree |
| Loyola University of Chicago | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 3 |
|---|---|
Zymergen, Inc.
 Zymergen, Inc. Miscellaneous Commercial ServicesCommercial Services Zymergen, Inc. engages in the design, development, and commercialization of bio-based products. Its products include electronic films, repellent products, and agriculture products such as traditional synthetic nitrogen fertilizers and traditional chemical-based crop protection products. The company was founded by Zachariah Serber, Jed Dean and Joshua J. Hoffman in 2013 and is headquartered in Emeryville, CA. | Commercial Services |
Korro Bio, Inc.
Korro Bio, Inc. BiotechnologyHealth Technology Korro Bio, Inc. engages in the development of a bio therapeutics. It focuses on a proprietary platform designed to selectively edit messenger RNA and recode specific codons to effect changes in protein structure and function across multiple tissues. The company was founded by Jean-Fran?ois Formela, Josh Rosenthal, Nessan Bermingham, and Andrew Fraley in 2018 and is headquartered in Cambridge, MA. | Health Technology |
Lodo Therapeutics Corp.
Lodo Therapeutics Corp. BiotechnologyHealth Technology Lodo Therapeutics Corp. engages in the development of novel therapeutics from its metagenomics-based small molecule discovery platform. Its Lodo platform leverages breakthroughs in next-generation sequencing (NGS), artificial intelligence (AI), and machine learning (ML), along with advances in synthetic biology and automation. The company was founded by Sean Brady and David L. Pompliano and is headquartered in New York, NY. | Health Technology |
- Stock Market
- Insiders
- Steve Colletti
